C Paraskeva
- Molecular Biology top 10%
- Oncology top 5%
- Pharmacology top 2%
- Cancer Research top 5%
- Genetics top 5%
- Co-authors
- Angela HagueAndrew HagueDaniel HicksDouglas J.E. ElderL. I. HuschtschaDavid A. HartAnthony M. ManningAnn C. Williams
- Topics
- Colorectal Cancer Treatments and Studies (6 papers)Inflammatory mediators and NSAID effects (5 papers)Genetic factors in colorectal cancer (4 papers)
- Cited by
- PharmacologyCancer ResearchOncology
- Partner nations
- United KingdomUnited StatesAustralia
In The Last Decade
C Paraskeva
21 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 95
- Molecular Biology 1.0k
- Oncology 606
- Pharmacology 451
- Cancer Research 378
- Genetics 346
Countries citing papers authored by C Paraskeva
This map shows the geographic impact of C Paraskeva's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C Paraskeva with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C Paraskeva more than expected).
Fields of papers citing papers by C Paraskeva
This network shows the impact of papers produced by C Paraskeva. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C Paraskeva. The network helps show where C Paraskeva may publish in the future.
Co-authorship network of co-authors of C Paraskeva
This figure shows the co-authorship network connecting the top 25 collaborators of C Paraskeva. A scholar is included among the top collaborators of C Paraskeva based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C Paraskeva. C Paraskeva is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 12 | |
| 2 | 7 | |
| 3 | 60 | |
| 4 | 37 | |
| 5 | 48 | |
| 6 | 174 | |
| 7 | 58 | |
| 8 | 35 | |
| 9 | 20 | |
| 10 | 23 | |
| 11 | 44 | |
| 12 | Induction of apoptotic cell death in human colorectal carcinoma cell lines by a cyclooxygenase-2 (COX-2)-selective nonsteroidal anti-inflammatory drug: independence from COX-2 protein expression. | 324 |
| 13 | Differential growth inhibition by the aspirin metabolite salicylate in human colorectal tumor cell lines: enhanced apoptosis in carcinoma and in vitro-transformed adenoma relative to adenoma relative to adenoma cell lines. | 153 |
| 14 | Mutant p53 is not fully dominant over endogenous wild type p53 in a colorectal adenoma cell line as demonstrated by induction of MDM2 protein and retention of a p53 dependent G1 arrest after gamma irradiation. | 20 |
| 15 | BCL-2 expression in human colorectal adenomas and carcinomas. | 148 |
| 16 | 100 | |
| 17 | 472 | |
| 18 | Biological consequences of the genetic changes which occur during human colorectal carcinogenesis. | 14 |
| 19 | 17 | |
| 20 | 5 |
About C Paraskeva
C Paraskeva is a scholar working on Biochemistry, Oncology and Cancer Research, having authored 21 papers that have together received 1.9k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (6 papers), Inflammatory mediators and NSAID effects (5 papers) and Genetic factors in colorectal cancer (4 papers). The work is most often cited by research in Pharmacology (451 citations), Cancer Research (378 citations) and Oncology (606 citations). C Paraskeva has collaborated with scholars based in United Kingdom, United States and Australia. Frequent co-authors include Angela Hague, Andrew Hague, Daniel Hicks, Douglas J.E. Elder, L. I. Huschtscha, David A. Hart, Anthony M. Manning, Ann C. Williams, M Moorghen and Matthew Chapman. Their work appears in journals such as Oncogene, British Journal of Cancer and Cell Death and Differentiation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.